Michael Coleman

Chief Executive Officer at Metaclipse Therapeutics Corporation - Atlanta, GA, US

Michael Coleman's Contact Details
HQ
404-380-1342
Location
Houston,Texas,United States
Company
Metaclipse Therapeutics Corporation
Michael Coleman's Company Details
Metaclipse Therapeutics Corporation logo, Metaclipse Therapeutics Corporation contact details

Metaclipse Therapeutics Corporation

Atlanta, GA, US • 20 - 49 Employees
BioTech/Drugs

Metaclipse Therapeutics is a preclinical stage biotech company developing novel cancer therapies that are tailored to each patient and their specific tumor. The Company's first ‘personalized' cancer therapy is for triple negative metastatic breast cancer. Metaclipse intends to commercialize its products through licensing agreements with major pharmaceutical companies after establishing their safety and effectiveness in early clinical trials by year-end 2019.

N/A
Details about Metaclipse Therapeutics Corporation
Frequently Asked Questions about Michael Coleman
Michael Coleman currently works for Metaclipse Therapeutics Corporation.
Michael Coleman's role at Metaclipse Therapeutics Corporation is Chief Executive Officer.
Michael Coleman's email address is ***@metaclipse.com. To view Michael Coleman's full email address, please signup to ConnectPlex.
Michael Coleman works in the Research industry.
Michael Coleman's colleagues at Metaclipse Therapeutics Corporation are Michael Coleman, Sampath Ramachandiran, Kristen Jacobsen, Swe-Htet Naing, Allison Blackerby, Chloe Wright, Rachana Adhikari and others.
Michael Coleman's phone number is 404-380-1342
See more information about Michael Coleman